换一批
换一批Effects of the anti-VEGF monoclonal antibody bevacizumab in a preclinical model and in patients with refractory and multiple relapsed Hodgkin lymphoma.
作者：
主题词
成年人(Adult);血管生成抑制剂(Angiogenesis Inhibitors);动物(Animals);抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细胞生长过程(Cell Growth Processes);脱氧胞苷(Deoxycytidine);疾病模型, 动物(Disease Models, Animal);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);霍奇金病(Hodgkin Disease);人类(Humans);免疫疗法(Immunotherapy);男(雄)性(Male);小鼠(Mice);小鼠, SCID(Mice, SCID);肿瘤移植(Neoplasm Transplantation);肿瘤负荷(Tumor Burden);血管内皮生长因子A(Vascular Endothelial Growth Factor A)
DOI
10.1097/CJI.0b013e3181a25daf
PMID
19609243
发布时间
2022-12-07
- 浏览26
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
